A recent NBC News article discussed the latest in its investigation into possible contaminants found in the popular heartburn drug Zantac. Tests conducted by the FDA found that the drug does not cause carcinogens to form in patients. The director of the FDA’s Center for Drug Evaluation and Research noted that the levels of NDMA are equivalent to what you might be exposed to while eating common foods like grilled or smoked meats. However, some versions of ranitidine (the generic form of Zantac) contained as much as nine times the acceptable limit for NDMA.
The FDA’s tests simulated how the drug reacts in a person’s stomach and small intestines. The next step is testing the drugs in human patients to fully understand the relationship with NDMA.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
